Browse > Article
http://dx.doi.org/10.3340/jkns.2015.58.2.93

A Role of Serum-Based Neuronal and Glial Markers as Potential Predictors for Distinguishing Severity and Related Outcomes in Traumatic Brain Injury  

Lee, Jae Yoon (Department of Neurosurgery, Konyang University Hospital)
Lee, Cheol Young (Department of Neurosurgery, Konyang University Hospital)
Kim, Hong Rye (Department of Neurosurgery, Konyang University Hospital)
Lee, Chang-Hyun (Department of Neurosurgery, Konyang University Hospital)
Kim, Hyun Woo (Department of Neurosurgery, Konyang University Hospital)
Kim, Jong Hyun (Department of Neurosurgery, Konyang University Hospital)
Publication Information
Journal of Korean Neurosurgical Society / v.58, no.2, 2015 , pp. 93-100 More about this Journal
Abstract
Objective : Optimal treatment decision and estimation of the prognosis in traumatic brain injury (TBI) is currently based on demographic and clinical predictors. But sometimes, there are limitations in these factors. In this study, we analyzed three central nervous system biomarkers in TBI patients, will discuss the roles and clinical applications of biomarkers in TBI. Methods : From July on 2013 to August on 2014, a total of 45 patients were included. The serum was obtained at the time of hospital admission, and biomarkers were extracted with centrifugal process. It was analyzed for the level of S-100 beta (S100B), glial fibrillary acidic protein (GFAP), and ubiquitin carboxy-terminal hydrolase-L1 (UCH-L1). Results : This study included 33 males and 12 females with a mean age of 58.5 (19-84) years. TBI patients were classified into two groups. Group A was severe TBI with Glasgow Coma Scale (GCS) score 3-5 and Group B was mild TBI with GCS score 13-15. The median serum concentration of S100B, GFAP, and UCH-L1 in severe TBI were raised 5.1 fold, 5.5 fold, and 439.1 fold compared to mild injury, respectively. The serum levels of these markers correlated significantly with the injury severity and clinical outcome (p<0.001). Increased level of markers was strongly predicted poor outcomes. Conclusion : S100B, GFAP, and UCH-L1 serum level of were significantly increased in TBI according to severity and associated clinical outcomes. Biomarkers have potential utility as diagnostic, prognostic, and therapeutic adjuncts in the setting of TBI.
Keywords
Brain injuries; Biological markers; S100 Calcium Binding Protein beta Subunit; Glial fibrillary acidic protein; Ubiquitin thiolesterase;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Alpert JS, Thygesen K, Antman E, Bassand JP : Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36 : 959-969, 2000   DOI
2 Anderson RE, Hansson LO, Nilsson O, Dijlai-Merzoug R, Settergren G : High serum S100B levels for trauma patients without head injuries. Neurosurgery 48 : 1255-1258; discussion 1258-1260, 2001
3 Baker SP, O'Neill B, Haddon W Jr, Long WB : The injury severity score : a method for describing patients with multiple injuries and evaluating emergency care. J Trauma 14 : 187-196, 1974   DOI
4 Bell MJ, Kochanek PM, Heyes MP, Wisniewski SR, Sinz EH, Clark RS, et al. : Quinolinic acid in the cerebrospinal fluid of children after traumatic brain injury. Crit Care Med 27 : 493-497, 1999   DOI
5 Berger RP, Beers SR, Richichi R, Wiesman D, Adelson PD : Serum biomarker concentrations and outcome after pediatric traumatic brain injury. J Neurotrauma 24 : 1793-1801, 2007   DOI
6 Berger RP, Pierce MC, Wisniewski SR, Adelson PD, Clark RS, Ruppel RA, et al. : Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatrics 109 : E31, 2002   DOI
7 Dimopoulou I, Korfias S, Dafni U, Anthi A, Psachoulia C, Jullien G, et al. : Protein S-100b serum levels in trauma-induced brain death. Neurology 60 : 947-951, 2003   DOI
8 Hamm CW, Katus HA : New biochemical markers for myocardial cell injury. Curr Opin Cardiol 10 : 355-360, 1995   DOI
9 Hans P, Born JD, Albert A : "Extrapolated" creatine kinase-BB isoenzyme activity in assessment of initial brain damage after severe head injury. J Neurosurg 66 : 714-717, 1987   DOI
10 Hoge CW, McGurk D, Thomas JL, Cox AL, Engel CC, Castro CA : Mild traumatic brain injury in U.S. Soldiers returning from Iraq. N Engl J Med 358 : 453-463, 2008   DOI
11 Kleiman NS, Lakkis N, Cannon CP, Murphy SA, DiBattiste PM, Demopoulos LA, et al. : Prospective analysis of creatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non-ST-elevation acute coronary syndromes. J Am Coll Cardiol 40 : 1044-1050, 2002   DOI
12 Kruse A, Cesarini KG, Bach FW, Persson L : Increases of neuron-specific enolase, S-100 protein, creatine kinase and creatine kinase BB isoenzyme in CSF following intraventricular catheter implantation. Acta Neurochir (Wien) 110 : 106-109, 1991   DOI
13 Middeldorp J, Hol EM : GFAP in health and disease. Prog Neurobiol 93 : 421-443, 2011   DOI
14 Mishra A, Srivastava C, Singh SK, Chandra A, Ojha BK : Choroid plexus carcinoma : case report and review of literature. J Pediatr Neurosci 7 : 71-73, 2012   DOI
15 Missler U, Wiesmann M, Friedrich C, Kaps M : S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke 28 : 1956-1960, 1997   DOI
16 Missler U, Wiesmann M, Wittmann G, Magerkurth O, Hagenstrom H : Measurement of glial fibrillary acidic protein in human blood : analytical method and preliminary clinical results. Clin Chem 45 : 138-141, 1999
17 Morganti-Kossmann MC, Hans VH, Lenzlinger PM, Dubs R, Ludwig E, Trentz O, et al. : TGF-beta is elevated in the CSF of patients with severe traumatic brain injuries and parallels blood-brain barrier function. J Neurotrauma 16 : 617-628, 1999   DOI
18 Papa L, Lewis LM, Silvestri S, Falk JL, Giordano P, Brophy GM, et al. : Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention. J Trauma Acute Care Surg 72 : 1335-1344, 2012   DOI
19 Park JE, Kim SH, Yoon SH, Cho KG, Kim SH : Risk Factors Predicting Unfavorable Neurological Outcome during the Early Period after Traumatic Brain Injury. J Korean Neurosurg Soc 45 : 90-95, 2009   DOI
20 Pelinka LE, Kroepfl A, Leixnering M, Buchinger W, Raabe A, Redl H : GFAP versus S100B in serum after traumatic brain injury : relationship to brain damage and outcome. J Neurotrauma 21 : 1553-1561, 2004   DOI
21 Pickett W, Ardern C, Brison RJ : A population-based study of potential brain injuries requiring emergency care. CMAJ 165 : 288-292, 2001
22 Raabe A, Grolms C, Sorge O, Zimmermann M, Seifert V : Serum S-100B protein in severe head injury. Neurosurgery 45 : 477-483, 1999   DOI
23 Ross SA, Cunningham RT, Johnston CF, Rowlands BJ : Neuron-specific enolase as an aid to outcome prediction in head injury. Br J Neurosurg 10 : 471-476, 1996   DOI
24 Schafer BW, Heizmann CW : The S100 family of EF-hand calcium-binding proteins : functions and pathology. Trends Biochem Sci 21 : 134-140, 1996   DOI
25 Siman R, Toraskar N, Dang A, McNeil E, McGarvey M, Plaum J, et al. : A panel of neuron-enriched proteins as markers for traumatic brain injury in humans. J Neurotrauma 26 : 1867-1877, 2009   DOI
26 Usui A, Kato K, Abe T, Murase M, Tanaka M, Takeuchi E : S-100ao protein in blood and urine during open-heart surgery. Clin Chem 35 : 1942-1944, 1989
27 van Geel WJ, de Reus HP, Nijzing H, Verbeek MM, Vos PE, Lamers KJ : Measurement of glial fibrillary acidic protein in blood : an analytical method. Clin Chim Acta 326 : 151-154, 2002   DOI
28 Yamazaki Y, Yada K, Morii S, Kitahara T, Ohwada T : Diagnostic significance of serum neuron-specific enolase and myelin basic protein assay in patients with acute head injury. Surg Neurol 43 : 267-270; discussion 270-271, 1995   DOI
29 Zimmer DB, Cornwall EH, Landar A, Song W : The S100 protein family : history, function, and expression. Brain Res Bull 37 : 417-429, 1995   DOI
30 Yoon KH, Han KS, Sung MM : Fabrication of a new type of organic-inorganic hybrid superlattice films combined with titanium oxide and polydiacetylene. Nanoscale Res Lett 7 : 71, 2012   DOI
31 Zoltewicz JS, Scharf D, Yang B, Chawla A, Newsom KJ, Fang L : Characterization of antibodies that detect human GFAP after traumatic brain injury. Biomark Insights 7 : 71-79, 2012
32 Hammond FM, Grattan KD, Sasser H, Corrigan JD, Bushnik T, Zafonte RD : Long-term recovery course after traumatic brain injury : a comparison of the functional independence measure and disability rating scale. J Head Trauma Rehabil 16 : 318-329, 2001   DOI
33 Eccles MP, Foy R, Sales A, Wensing M, Mittman B : Implementation Science six years on--our evolving scope and common reasons for rejection without review. Implement Sci 7 : 71, 2012   DOI
34 Jackson P, Thompson RJ : The demonstration of new human brain-specific proteins by high-resolution two-dimensional polyacrylamide gel electrophoresis. J Neurol Sci 49 : 429-438, 1981   DOI
35 Mondello S, Linnet A, Buki A, Robicsek S, Gabrielli A, Tepas J, et al. : Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury. Neurosurgery 70 : 666-675, 2012
36 Saatman KE, Duhaime AC, Bullock R, Maas AI, Valadka A, Manley GT, et al. : Classification of traumatic brain injury for targeted therapies. J Neurotrauma 25 : 719-738, 2008   DOI